Go to the page content
Obesity

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

Locations

China

Start date

09/02/2025

Identifiers

Trial ID NN9487-7573,
NCT number NCT06820476,
Eudract number Not Available

Summary

The study is testing a new study medicine called NNC0487-0111 for weight control in Chinese people with Body mass index (BMI) greater than or equal to (\>=) 24 kilogram per square meter (kg/m\^2). The aim of this study is to find out how safe the study medicine is and how it behaves in your body. Participants will either get NNC0487-0111 or placebo. Which treatment participants will get is decided by chance. Oral NNC0487-0111 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. The study will last for about 60 days.

Trial Overview:

Condition

Overweight

Obesity

Treatment

DRUG: NNC0487-0111

DRUG: Placebo (NNC0487-0111)

Study type

INTERVENTIONAL

Trial duration

Feb 09 2025 - May 23 2025

Participants

36

Phase

I

Are you eligible?

Gender

MALE

Age

18 to 55 years old

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.